Challenges and opportunities of pharmacogenetics in drug development

ISSN： 1741-0541

Source： Personalized Medicine, Vol.3, Iss.2, 2006-05, pp. : 195-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Pharmacogenetics in Rational Development and Personalization of Drug Treatments

By Marsh Sharon

Personalized Medicine, Vol. 2, Iss. 1, 2005-02 ,pp. : 13-14

Future Medicine

Access to resources Recommend Favorite

Trial geography, pharmacogenetics, and global drug development

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 3, 2015-03 ,pp. : 218-220

John Wiley & Sons Inc

Access to resources Recommend Favorite

Community development in primary care: opportunities and challenges

By Hogg Rhona Hanley Janet

Community Practitioner, Vol. 81, Iss. 1, 2008-01 ,pp. : 22-25

Community Practitioner

Access to resources Recommend Favorite

Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases–U.S. Food and Drug Administration Joint Workshop

HEPATOLOGY, Vol. 61, Iss. 4, 2015-04 ,pp. : 1392-1405

John Wiley & Sons Inc

Access to resources Recommend Favorite

Challenges and Opportunities in the Development of Medical Therapies for Pediatric Populations and the Role of Extrapolation

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 3, 2018-03 ,pp. : 419-433

John Wiley & Sons Inc

Access to resources Recommend Favorite